These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1886176)
21. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2. Bonavida B; Katz J; Gottlieb M J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345 [TBL] [Abstract][Full Text] [Related]
22. [In vitro and in vivo studies with interleukin 2 (IL-2) and various immunostimulants in a patient with AIDS]. Vaith P; Maas D; Feigl D; Hauke G; Lang B; Oepke G; Stierle HE; Bross KJ; Andreesen R; Gross G Immun Infekt; 1985 Apr; 13(2):51-63. PubMed ID: 2581885 [TBL] [Abstract][Full Text] [Related]
23. New medicines in development for AIDS: 1994 survey from the Pharmaceutical Research and Manufacturers of America. Pediatr AIDS HIV Infect; 1995 Apr; 6(2):101-10. PubMed ID: 11361382 [No Abstract] [Full Text] [Related]
24. Immune boosters. Focus on the immune system. TreatmentUpdate; 2001; 12(12):12. PubMed ID: 11570077 [No Abstract] [Full Text] [Related]
26. [Pathogenesis and therapy of persistent infections associated with immunodeficiency syndromes]. Votiakov VI; Kolomiets AG Klin Med (Mosk); 1991 May; 69(5):29-37. PubMed ID: 1649934 [No Abstract] [Full Text] [Related]
27. Essiac. Majchrowicz MA Notes Undergr; 1995; (no 29):6-7. PubMed ID: 11362284 [TBL] [Abstract][Full Text] [Related]
28. [Immunomodulating treatment of patients with HIV infection]. Skotnicki AB; Kornaszewski W Przegl Dermatol; 1989; 76(4):285-91. PubMed ID: 2483589 [No Abstract] [Full Text] [Related]
29. [Viruses as immunosuppressor agents: therapeutic intervention with antiviral agents and modifiers of the biological response]. Fernández-Cruz E Rev Clin Esp; 1988 Mar; 182(5):245-9. PubMed ID: 2840693 [No Abstract] [Full Text] [Related]
30. [Use of intravenous immunoglobulins in pediatrics]. Duse M; Plebani A; Crispino P; Ugazio AG Pediatr Med Chir; 1991; 13(2):117-25. PubMed ID: 1896376 [TBL] [Abstract][Full Text] [Related]
31. Current treatment for human immunodeficiency virus infection. Falloon J Ear Nose Throat J; 1990 Jul; 69(7):487-96. PubMed ID: 2205473 [TBL] [Abstract][Full Text] [Related]
32. [New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists]. Gause A; Sahin U; Pfreundschuh M Dtsch Med Wochenschr; 1992 Nov; 117(46):1764-73. PubMed ID: 1425297 [No Abstract] [Full Text] [Related]
33. Designing CD4 immunoadhesins for AIDS therapy. Capon DJ; Chamow SM; Mordenti J; Marsters SA; Gregory T; Mitsuya H; Byrn RA; Lucas C; Wurm FM; Groopman JE Nature; 1989 Feb; 337(6207):525-31. PubMed ID: 2536900 [TBL] [Abstract][Full Text] [Related]
34. [The monocyte-macrophage system and acquired immunodeficiency syndrome (AIDS)]. Ercoli L; Perno CF; Bergamini A; Rocchi G Medicina (Firenze); 1990; 10(1):1-8. PubMed ID: 2199742 [TBL] [Abstract][Full Text] [Related]
35. Immunomodulating peptides of natural and synthetic origin. St Georgiev V Med Res Rev; 1991 Jan; 11(1):81-119. PubMed ID: 1994154 [No Abstract] [Full Text] [Related]
36. The effect of supplemental beta-carotene on immunologic indices in patients with AIDS: a pilot study. Fryburg DA; Mark RJ; Griffith BP; Askenase PW; Patterson TF Yale J Biol Med; 1995; 68(1-2):19-23. PubMed ID: 8748463 [TBL] [Abstract][Full Text] [Related]
38. The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants. Sasaki S; Tsuji T; Asakura Y; Fukushima J; Okuda K Anticancer Res; 1998; 18(5D):3907-15. PubMed ID: 9854503 [TBL] [Abstract][Full Text] [Related]
39. Serotherapy for AIDS and pre-AIDS syndrome. Sewell HF; Walker F Nature; 1986 Mar 13-19; 320(6058):113-4. PubMed ID: 3081817 [No Abstract] [Full Text] [Related]